NAS10029,813+0.55%S&P7,744+0.28%GOLD$4,077+0.07%BTC$81,598+0.98%VIX16.87−3.71%latest tape · as of 20:04 UTC
The Screen · Industrials · Specialty Industrial Machinery
ATS Corporation
ATS · the NYSE · USD · Market cap $1.8B · 7,000 employees
ATS Corporation, together with its subsidiaries, engages in the planning, designing, building, commissioning, and servicing of automated manufacturing and assembly systems worldwide.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.37, read 2026-10-27
Ethical passes the values gate
Price18.95 USD
Fair value22.34
Ethical score70.0/100
Our investment reviews on this name
2026-10-27Read Accumulation18.70+1.3% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-09-24Read Markdown19.16-1.1% to today ✓Distribution gives way to Markdown after a 9% slide in 5 weeks
2026-08-22Read Distribution21.13-10.3% to today ✓Markup gives way to Distribution after a 23% slide in 7 weeks
2026-07-02Read Markup27.37-30.8% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
ATS Corporation holds its Markdown at $18.95. The statistical read favours the buyers, held for 1 days.
As held on the ledger · 2026-10-26
Phase
Markdown · caution
Quantitative state
The statistical read favours the buyers, held for 1 days
Price at the screen
$18.95
Valuation
53.43 trailing · 13.73 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.12
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
33.09%
Below 33%
Interest-bearing debt is just 33.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
18.63%
Below 49%
Money owed to the company is 18.6% of assets, under the 49% limit.
Pass
Revenue purity
0.03%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
ATS clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ATS's ethical verdict changes
Today ATS passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-26 screen. The gold marker is the market price at the same screen. A 19.5% margin of safety to the base estimate.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Automation Growth Masks Thin Profits And Low Returns
Picture a factory floor humming with custom robots and assembly lines built for car makers or medical device plants. ATS designs and installs those systems worldwide and revenue is rising 30% a year. Yet the business earns just a 2% profit margin and delivers only 4% return on equity while trading above our fair value estimate with a negative margin of safety.
The forward multiple of 17 times earnings looks reasonable on paper but offers little compensation for the weak returns and unknown competitive edge. Ethical screens are cleared yet the core economics remain unattractive at current levels so the opportunity rating stays at none.
Low margins leave scant buffer if project delays or customer capex cuts hit in a cyclical sector. The stock needs clearer proof of sustained profitability before it becomes compelling. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ATS trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-10-20Markdown$18.09+2.5%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-10-13Markdown$17.65-7.9%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-10-02Markdown$19.16+0.0%Entry 7
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-09-24Markdown · changed$19.16-9.3%Entry 6
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 23.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-07-22Markup$27.58+0.8%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-07-18Markup$27.37+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-07-03Markup$27.37+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$27.37Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
